- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about RXRX
Recent news which mentions RXRX
3 Biotech Stocks You Can Buy and Hold for the Next Decade
January 15, 2024
From Motley Fool
Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights
January 13, 2024
From Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
From Motley Fool
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
January 09, 2024
Tickers
RXRX
From InvestorPlace
What's Going On With Recursion Pharmaceuticals Stock?
January 09, 2024
From Benzinga
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
January 09, 2024
From Benzinga
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
From Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024
January 03, 2024
From Motley Fool
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
January 02, 2024
From Benzinga
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
From InvestorPlace
Peering Into Recursion Pharmaceuticals's Recent Short Interest
January 01, 2024
Tickers
RXRX
From Benzinga
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
From InvestorPlace
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
From Motley Fool
2 Cathie Wood Stocks That Might Be Smart Buys Right Now
December 17, 2023
From Motley Fool
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
December 16, 2023
From InvestorPlace
Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock
December 14, 2023
From InvestorPlace
Looking Into Recursion Pharmaceuticals's Recent Short Interest
December 06, 2023
Tickers
RXRX
From Benzinga
Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday
November 29, 2023
From Benzinga
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
November 26, 2023
Tickers
RXRX
From Motley Fool
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
November 23, 2023
From InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
November 22, 2023
From Motley Fool
This Stock Could Soar by 120%, According to Wall Street
November 22, 2023
Tickers
RXRX
From Motley Fool
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?
November 21, 2023
Tickers
RXRX
From Motley Fool
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
November 13, 2023
From Benzinga
From InvestorPlace
3 Stocks to Buy for Their Proximity to Nvidia
November 08, 2023
From InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
From Benzinga
The 7 Best Cathie Wood Stocks to Buy Now: November Edition
November 01, 2023
From InvestorPlace
2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell
October 31, 2023
Tickers
RXRX
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.